Dr. Stevenson presentation
This presentation describes a study we conducted (it has been published in AJHP) in US health systems that examined the degree of digital inventory visibility and where gaps exist. It also discusses why digital inventory visibility is important to achieving better outcomes and steps that we can take to improve the degree of visibility.

Ms. Tan presentation:
This presentation will describe the Inpatient Pharmacy Automation System (IPAS) at Sengkang General Hospital. It will discuss unit-dose medication systems and the workflow and safety benefits of automated dispensing in the inpatient pharmacy and on patient care wards

Moderator:
- Rob Moss, Netherlands

Panellists:
- James Stevenson, Professor Emeritus University of Michigan College of Pharmacy, USA
- Angelina Tan, Deputy Director and Head of Pharmacy, Sengkang General Hospital, Singapore

Ms. Tan presentation:

This presentation will describe the Inpatient Pharmacy Automation System (IPAS) at Sengkang General Hospital. It will discuss unit-dose medication systems and the workflow and safety benefits of automated dispensing in the inpatient pharmacy and on patient care wards

As we approach a post-pandemic world, the global supply chain has been greatly influenced by various factors. Many different drug and product shortages have been exacerbated in recent years due to supply chain issues. Through this webinar, we want to give a better overview of understanding the current global supply chain, current threats to the supply chain such as drug shortages, natural disasters, counterfeit medicines, and how to create a resilient supply chain as we move forward in society. We also want to emphasize the value of a pharmacist in this area and the difference they can make.

Learning Objectives:
1. Describe the current global pharmacy supply chain
2. Compare the contrast the different threats to the pharmacy supply chain such as drug shortages, natural disasters, and counterfeit medicines
3. Understand how these threats can interrupt the supply chain from each panel member’s perspective/countries
4. Outline how to create a resilient supply chain and future endeavours taking place to protect the supply chain (i.e., automation and technology)

Moderator:
- Rob Moss, PharmD, Immediate past president, FIP Hospital Pharmacy Section, FIP, European Association of Hospital Pharmacists, The Netherlands

Panellists:
- Yuh Lih Chang, PhD, RPh Director, Department of Pharmacy, Taipei Veterans General Hospital; Principal Investigator, National Drug Shortage management Project; Associate Professor, National Yang-Ming Chiao-Tung University, Taiwan Veterans General Hospital, National Yang-Ming Chiao-Tung University, Taiwan
- Dr. Sohail Fitieh, Ph.D, MS PLA, RPh, Pharmacy & Supply Chain Consultant, United Arab of Emirates
- Michael Ganio, Pharm.D., M.S., BCPS, FASHP, Senior Director, Pharmacy Practice and Quality, American Society for Health-System Pharmacists, USA

The FIP Hospital Pharmacy Section (HPS) has set out to develop its strategy for the next 5 years. In early 2022, the FIP HPS developed a survey to identify how the FIP HPS can assist FIP Vision/Mission and FIP Development Goals. This survey was sent to FIP Hospital Pharmacy Executive Committee members, Chairs of Committees/Observers, Past Executive Committee members, Hospital Pharmacy Member organisations and regional forums. Results of the survey will be presented with a discussion on the FIP HPS strategy.

Learning objectives:
- To know the results of the FIP HPS strategy survey
- To identify priorities areas for the FIP HPS over the next 5 years
- To participate in the future direction of the FIP HPS

Chair:
-Jonathan Penm, Secretary, FIP Hospital Pharmacy Section, Senior Lecturer The University of Sydney- Australia

Panelist:
-Robert Moss, President, FIP Hospital Pharmacy Section- the Netherlands

At this event on World AIDS day, we will explore the different roles pharmacists can have in the prevention and screening of HIV infections, as well as in providing care and support to people living with HIV, namely through medication management. Other roles for pharmacists include HIV prevention through dispensing and providing support to preexposure prophylaxis (PrEP), HIV testing and harm reduction strategies for IV drugs users.

The World Health Organization estimates that around 38 million people live with HIV globally. Although there is still no cure for HIV, with the advancement of therapies and increasing access to effective HIV prevention, diagnosis, treatment and care, including for opportunistic infections, HIV infection has become a manageable chronic health condition, enabling people living with HIV to lead long and healthy lives.

Learning objectives:
1. Describe the burden and characteristics of HIV globally.
2. Understand the possibilities of involvement of pharmacists in the clinical care of people living with HIV.
3. Describe the role of pharmacists in PrEP-related services.

Moderator:
- Victoria Garcia Cardenas, FIP Pharmacy Practice Research SIG, Chair Senior Lecturer University of Technology Sydney, Australia / Spain

Panelists:
- Sham Moodley, FIP CPS Exco Member, Pharmacist Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa
- Nelli Barrière, Project Manager, HIV Programmes and Advocacy International AIDS Society, Switzerland
- Pilar Taberner Bonastre, Hospital pharmacist, Hospital Universitario Arnau de Vilanova, Lleida Spain
- Katrina F. Ortblad, Assistant Professor Fred Hutchinson Cancer Research Center, United States of America
- Tessa Oraro-Lawrence, Project Manager, HIV Programmes and Advocacy International AIDS Society, Switzerland

Antimicrobial resistance (AMR) is a major public health threat, which currently kills around 700,000 people each year worldwide. The fight against AMR has been a priority for FIP for many years as it causes a profound impact on global, regional and national health care and economies. The goal of this webinar is to supplement the other FIP webinars being held in November 2021 discussing AMR regionally around the globe. This webinar specifically targets pharmacists involved in hospital and health-system practice settings and will discuss innovative ways to involve pharmacists in infectious disease through AMR and sepsis management.

Learning objectives:
1. Introduce the antimicrobial stewardship program in hospital pharmacy using clinical decision support system
2. Discuss the role and importance of the pharmacist in the management of sepsis
3. Evaluate the use of software and information technology to support antimicrobial stewardship in the critically ill

Moderator:
Krutika Mediwala Hornback, Clinical Pharmacy Specialist - Infectious Diseases/Antimicrobial Stewardship MUSC Health, USA

Panelists:
-Esteban Zavaleta, Director of Pharmacy, Hospital Clinica Biblica, Costa Rica
-Shu-Wen “Wendy” Lin, Director of Pharmacy, National Taiwan University Cancer Center, Taiwan
-Asad “Sid” Patanwala, Professor and Chair of Clinical Pharmacy University of Sydney | Royal Prince Alfred Hospital, Australia

Despite all good intentions, all humans carry unconscious biases. How do these impact our ability to provide culturally appropriate care to our patients? This interactive session is meant to target all pharmacists and educators in practice to promote understanding on the influence of unconscious bias on health disparities, like COVID-19. Specifically, experts will share the neuroscience of how implicit bias, strategies to disrupt bias, and address how bias can influence our patient care interactions.

At the end of this session, participants will be able to:
1. Define implicit bias and its impact on health disparities.
2. Discuss the impact of unconscious bias and how it affects our relationships with patients, students, and colleagues.
3. Identify and reflect on own biases.
4. List strategies to mitigate unconscious bias in pharmacy practice to improve patient-centred care.

Moderator:
- Mohamed Amin, Associate Professor, Beirut Arab University, Lebanon

Facilitator:
- Dalia Bajis, FIP lead for Provision and Partnerships, FIP, Bahrain

Panellist: 
- Sally Arif, Associate Professor of Pharmacy Practice/ Clinical Pharmacist, Midwestern University College of Pharmacy/ Rush University Medical Center, USA

This webinar will present the professional practice in the hospital setting using health digital technologies. Digital Innovation, how to develop digital skills in pharmacy personnel Telepharmacy and mHealth is the content of the first part. It is relevant to discuss “mHealth” because the access to mobile phones is almost universal and the costs of this technology will be able to be addressed by many countries. The objective of the second part will be: “Discuss current use of mHealth by patients and providers and the impact on hospital care in Midwestern United States” "Medication use technology" would complete the webinar.

Learning objectives:
1. Compare the “European” model of digital technologies for hospital pharmacy with the “American” one.
2. Explain the concept of medication error risk mitigation.
3. Get aware with Medication Use Technology employed throughout the medication use process

Moderator:
- Jacqueline Surugue, Chair of the FIP Pharmaceutical Technology Forum, France 

Panellists:
- José Manuel Martínez Sesmero, Director of Pharmacy in Hospital Clínico San Carlos (Madrid), Spain
- Katherine A. Miller, Sr. Director – Acute Care Pharmacy and Clinical Nutrition,The University of Kansas Health System, USA
- Dr. Johlee S. Odinet, Johlee S. Odinet Medication Safety Supervisor  Ochsner Medical Center, USA

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning objectives:
1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
-T.V. Narayana, President SEAR Pharm Forum, India

Panellists:
- Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan
- Luminita Constantin, Global Medical Lead CHC Pain, Sanofi, France
- Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK), United Kingdom
-Raj Vaidya, Community Pharmacist, Hindu Pharmacy, India

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning objectives:
1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
- Nadia Al Mazrouei, Assistant Professor, Sharjah University, United Arab Emirates (UAE)

Panellists:
-Takuya Kumamoto, Professor, Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan
-Luminita Constantin, Global Medical Lead CHC Pain, Sanofi, France
-Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK)-United Kingdom
-Abdulaziz khaled Alkhaledi, Member of Executive Committee, Kuwait Pharmaceutical Association, Kuwait State

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning objectives:1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
-Luis Lourenço, Professional Secretary, Community Pharmacy Section, Portugal

Panellists:
- Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan
- Luminita Constantin, Global Medical Lead CHC Pain, Sanofi, France
- Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK), United Kingdom
- Charlotte Verner Rossing, Vice-chair, FIP Special Interest Group on Pharmacy Practice Research FIP, Denmark

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning objectives:
1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
- Prosper Hiag, Member of the Council of the FIPm President African Pharmaceutical Forum (APF), Cameroon
Panellists:
-Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan
- Luminita Constantin, Global Medical Lead CHC Pain
Sanofi, France
- Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology King’s College (UK), United Kingdom
- Machi Hampango, Head Of Pharmacy Practice and Clinical Pharmacy, Faculty of Pharmacy, Nutrition and Dietetics, Lusaka Apex Medical University, Zambia

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.
Learning objectives:
1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
-John Jackson, President Western Pacific Pharmaceutical Forum, Australia
Panellists:
-Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan
-Luminita Constantin, Global Medical Lead CHC Pain Sanofi, France
-Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK), United Kingdom
- Daniel Malone, Director of Pharmacy Education Monash University, Melbourne, Australia

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning objectives:
1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
-Eduardo Savio, President Pharmaceutical Forum of the Americas, Uruguay

Panellists:
-Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima - Japan
- Luminita Constantin, Global Medical Lead CHC Pain Sanofi, France
- Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology King’s College (UK), United Kingdom
- Willington Montenegro, Manager Lider Pharmacy, Ecuador

This event is for hospital and health-system pharmacists and leaders to review best practices for advanced and specialist pharmacist development in the hospital setting. Content will include information about the European Association of Hospital Pharmacists (EAHP) Position Paper on Hospital Pharmacy Specialisation and the FIP Hospital Pharmacy Section Basel Statements in relation to the future of clinical pharmacy practice.

Learning objectives:
a. Have an increased awareness of the competencies required of a hospital pharmacist
b. Understand global initiatives in progression and recognition pathways for advanced practice and specialisation
c. Identify resources available for use of the FIP HPS Basel Statements in the hospital pharmacy advanced practice
d. Identify new competencies that hospital pharmacists will need in the future

Moderator:
- Lina Bader, FIP Lead for Workforce Transformation and Development, Saudi Arabia

Panellists:
- András Süle, EAHP President & Chief Pharmacist at the Péterfy Hospital – National Institute of Traumatology in Budapest Hungary, European Association of Hospital Pharmacists (EAHP), Hungary (home country), Belgium (country in which EAHP is based in)
- Kirstie Galbraith, Associate Director, Workforce Development Hub, Global Lead, Advanced and Speciality practice (DG4), Workforce Development Hub, Director, Experiential Development and Graduate Education, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University - Australia
- Josep Maria Guiu Segura, Vice-president Euro, Hospital Pharmacy Section, International Pharmaceutical Federation, Director of Pharmacy and Medicines, Consortium of Health and Social Care of Catalonia - Spain

A Direct Application of the FIP Basel Statements on Human Resources, Training and Development & Aligned with FIP Development Goals.

Both the FIP Development Goals and the Hospital Pharmacy Section Basel Statements list the competency of the pharmacy workforce as important. In a listing of priority goals from the DG and the BS, FIP members identify competency goals as a top priority. The HPS Vice Presidents also list competency as a high priority for advancing hospital pharmacy practice. The webinar will address curricula and ongoing continuing education to provide students and practitioners with the necessary knowledge and skills for contemporary hospital pharmacy services.

Moderator:
- Marianne F. Ivey, Professor Emerita, Pharmacy Practice and Administrative Sciences, University of Cincinnati - USA

Panellist:
- Daniel Kibuule, Associate Dean, - Hage Geingob Campus, University of Namibia - Namibia
- Salwa Ahsan, Chief of Pharmacy, Shifa International Hospitals Ltd., H-8/4, Islamabad - Pakistan

This webinar will provide an educational programme to support hospital pharmacists in developing preceptor skills, especially with regards to currently trending areas in pharmacy education. Furthermore, commonly encountered challenges and potential solutions to address them will be presented.

At the end of this webinar, attendees will be able to:

- Utilise skills and strategies to effectively precept students, residents, and interns in the hospital setting
- Incorporate preceptor skills with regards to currently trending areas in pharmacy education
- Address commonly encountered challenges as a preceptor using different potential solutions

Moderator:
- Marianne F. Ivey, Professor Emerita, Pharmacy Practice & Administrative Services, University of Cincinnati - USA

Speakers:
- Phuoc Anne Nguyen, Pharmacy Manager, Houston Methodist West Hospital - USA
- Salwa Ahsan, Chief of Pharmacy, Shifa International Hospitals Ltd. - Pakistan
- Matthew Hung, Clinical Staff Pharmacist, St. Mary’s Hospital, Montreal West Island Integrated University Health and Social Services Centre - Canada

Speakers:
Marianne Ivey, Professor Emerita, Pharmacy Practice and Administrative Sciences FIP - USA
Jonathan Penm, Lecturer University of Sydney - Australia

*Moderator: John Hertig

*Speakers: Mário Borges Rosa and Michael R. Cohen

FIP’s Hospital Pharmacy Section is organising a webinar on “Good storage and distribution practices for pharmaceutical products in hospitals”.

The correct storage and distribution and the continuous improvement of the processes involved in the supply chain from the acquisition to the administration or use of pharmaceutical products in hospitals, have a direct economic impact and improves quality assurance in patients care.

Learning objectives:

1. Understand variables that affect the stability of pharmaceutical products.

2. Understand storage and distribution processes.

3. Evaluate good storage and distribution practices that improves quality processes.

4. Highlight new technologies that benefit good practices for pharmaceutical products.

Presentation outline:

- Define variables that affect the stability of pharmaceutical products.

- Define storage and distribution processes for pharmaceutical products.

- Provide examples of good practices.

- Present new technologies that benefit good practices of storage and distribution.

Moderator: Nora Gerpe

Speakers: Martín G. Silveira and Javier Movilla

fip, webinar, hps

HPS - Substandard, Spurious, Falsely Labelled, Falsified, and Counterfeit (SSFFC) Medication Issues and Managem